miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma

Oral Dis. 2013 Sep;19(6):611-9. doi: 10.1111/odi.12046. Epub 2012 Dec 12.

Abstract

Background: MicroRNAs play important roles in carcinogenesis. A preliminary screening study suggested that down-regulation of miR-370 occurs in oral squamous cell carcinoma (OSCC) tissue. Insulin receptor substratre-1 (IRS-1) is the substrate of insulin-like growth factor receptor (IGFR), which modulates AKT/mTOR activation in malignancies. The relationship between miR-370 and IRS-1, and their functional roles in OSCC pathogenesis are unclear.

Materials and methods: Primary OSCC specimens were examined for miR-370 expression. Exogenous expression of miR-370 was established using both stable subclones and transient expression, and these were used to gain insights into miR-370's functions in OSCC cells. Knockdown of miR-370 and IRS-1 was also carried out in OSCC cells using a small interference oligonucleotide approach.

Results: Squamous cell carcinoma tissues with perineural invasion had lowered miR-370 expression compared with contrasting OSCC. OSCC cells also exhibited lower miR-370 expression than normal oral keratinocytes, and this can be reversed by treatment with 5-aza-2'-deoxycytidine. Exogenous miR-370 expression decreases the migration and anchorage-independent growth of OSCC cells, which implies a suppressor role for miR-370. The enhancement of anchorage-independent growth of OSCC cells through miR-370 inhibiting can be reduced by knockdown of IRS-1 expression.

Conclusion: This study concludes that miR-370 is able to target IRS-1 for oral tumorigenesis.

Keywords: IRS-1; carcinoma; miR-370; mouth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Azacitidine / analogs & derivatives
  • Azacitidine / pharmacology
  • Carcinogenesis / pathology
  • Carcinoma, Squamous Cell / pathology*
  • Cell Adhesion / genetics
  • Cell Culture Techniques
  • Cell Line, Tumor
  • Cell Movement / genetics
  • Cells, Cultured
  • DNA Modification Methylases / antagonists & inhibitors
  • Decitabine
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic / genetics
  • Gene Knockdown Techniques
  • Humans
  • Insulin Receptor Substrate Proteins / genetics
  • Insulin Receptor Substrate Proteins / physiology*
  • Keratinocytes / drug effects
  • Keratinocytes / pathology
  • MicroRNAs / analysis
  • MicroRNAs / genetics
  • MicroRNAs / physiology*
  • Mouth Neoplasms / pathology*
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Oncogene Protein v-akt / physiology
  • RNA, Small Interfering / genetics
  • TOR Serine-Threonine Kinases / physiology

Substances

  • IRS1 protein, human
  • Insulin Receptor Substrate Proteins
  • MIRN370 microRNA, human
  • MicroRNAs
  • RNA, Small Interfering
  • Decitabine
  • DNA Modification Methylases
  • MTOR protein, human
  • Oncogene Protein v-akt
  • TOR Serine-Threonine Kinases
  • Azacitidine